Early antiviral use and supplemental oxygen decrease the risk of secondary bacterial infections: a multi-centre, nested, case–control study

IF 3.9 3区 医学 Q1 INFECTIOUS DISEASES Journal of Hospital Infection Pub Date : 2025-02-01 DOI:10.1016/j.jhin.2024.12.005
Y. Zhu , H. Hu , X. Guo , H. Zhang , D. Li , C.S. Dela Cruz , W. Xie , L. Xie , L. Sharma , D. Chang
{"title":"Early antiviral use and supplemental oxygen decrease the risk of secondary bacterial infections: a multi-centre, nested, case–control study","authors":"Y. Zhu ,&nbsp;H. Hu ,&nbsp;X. Guo ,&nbsp;H. Zhang ,&nbsp;D. Li ,&nbsp;C.S. Dela Cruz ,&nbsp;W. Xie ,&nbsp;L. Xie ,&nbsp;L. Sharma ,&nbsp;D. Chang","doi":"10.1016/j.jhin.2024.12.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The purpose of this study was to evaluate the treatment strategies that dictate the host susceptibility to secondary bacterial infections during coronavirus disease 2019 (COVID-19).</div></div><div><h3>Methods</h3><div>This nested, case–control study was conducted in three general hospitals in China between 1<sup>st</sup> December 2022 and 1<sup>st</sup> March 2023. A total of 456 confirmed COVID-19 patients matched 1:2 (152 cases and 304 controls) based on age, sex, disease severity and age-adjusted Charlson Comorbidity Index (aCCI) using propensity-score matching (PSM) were included. Association of secondary bacterial infections with treatment strategies including the supportive measures, antiviral, and antibacterial therapies were the main outcome measures.</div></div><div><h3>Findings</h3><div>Conditional logistic regression analyses demonstrated that among categorical variables, use of antibiotics, antivirals, intravenous injection of human immunoglobulin, glucocorticoids or anticoagulants were not associated with the risk of secondary bacterial infections in the COVID-19 patients. The use of supplemental oxygen by either low (odds ratio (OR): 0.18, <em>P</em>&lt;0.001) or high flow (OR: 0.06, <em>P</em>&lt;0.001), but not through ventilators were associated with significant protection against secondary bacterial infection. In contrast, feeding through gastric tube (OR: 10.97, <em>P</em>&lt;0.001) or parenteral nutrition (OR: 3.97, <em>P</em>=0.002) was associated with significant increase in the risk of secondary bacterial infections. Similar data were obtained when data were analysed using continuous variables. Further, the early (&lt;5 days post symptom onset, OR: 0.09, <em>P</em>&lt;0.001), but not the late use of antivirals was associated with protection against secondary bacterial infections.</div></div><div><h3>Conclusions</h3><div>Oxygen supplementation in non-ventilator settings and early use of antivirals were associated with decreased incidences of secondary bacterial infections, while parenteral nutrition or tube feedings were associated with increased incidences of secondary bacterial infections.</div></div>","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":"156 ","pages":"Pages 87-95"},"PeriodicalIF":3.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hospital Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0195670124004079","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The purpose of this study was to evaluate the treatment strategies that dictate the host susceptibility to secondary bacterial infections during coronavirus disease 2019 (COVID-19).

Methods

This nested, case–control study was conducted in three general hospitals in China between 1st December 2022 and 1st March 2023. A total of 456 confirmed COVID-19 patients matched 1:2 (152 cases and 304 controls) based on age, sex, disease severity and age-adjusted Charlson Comorbidity Index (aCCI) using propensity-score matching (PSM) were included. Association of secondary bacterial infections with treatment strategies including the supportive measures, antiviral, and antibacterial therapies were the main outcome measures.

Findings

Conditional logistic regression analyses demonstrated that among categorical variables, use of antibiotics, antivirals, intravenous injection of human immunoglobulin, glucocorticoids or anticoagulants were not associated with the risk of secondary bacterial infections in the COVID-19 patients. The use of supplemental oxygen by either low (odds ratio (OR): 0.18, P<0.001) or high flow (OR: 0.06, P<0.001), but not through ventilators were associated with significant protection against secondary bacterial infection. In contrast, feeding through gastric tube (OR: 10.97, P<0.001) or parenteral nutrition (OR: 3.97, P=0.002) was associated with significant increase in the risk of secondary bacterial infections. Similar data were obtained when data were analysed using continuous variables. Further, the early (<5 days post symptom onset, OR: 0.09, P<0.001), but not the late use of antivirals was associated with protection against secondary bacterial infections.

Conclusions

Oxygen supplementation in non-ventilator settings and early use of antivirals were associated with decreased incidences of secondary bacterial infections, while parenteral nutrition or tube feedings were associated with increased incidences of secondary bacterial infections.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
早期使用抗病毒药物和补充氧气可降低继发性细菌感染的风险:一项多中心巢式病例对照研究
目的:评价2019冠状病毒病(COVID-19)期间宿主对继发性细菌感染易感性的治疗策略。设计:环境和参与者:本巢式病例对照研究于2022年12月1日至2023年3月1日在中国三家综合医院进行。采用倾向-评分匹配(PSM)方法将年龄、性别、疾病严重程度和年龄校正Charlson合并症指数(aCCI)按1:2匹配的确诊COVID-19患者456例(152例,对照组304例)纳入研究。主要观察指标:继发性细菌感染与治疗策略的相关性,包括支持措施、抗病毒和抗菌治疗。结果:条件logistic回归分析显示,在分类变量中,抗生素、抗病毒药物、静脉注射人免疫球蛋白、糖皮质激素和抗凝药物的使用与COVID-19患者继发细菌感染的风险无关。结论:在非呼吸机环境下补充氧气和早期使用抗病毒药物与继发细菌感染的发生率降低有关,而肠外营养或管饲与继发细菌感染的发生率增加有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Hospital Infection
Journal of Hospital Infection 医学-传染病学
CiteScore
12.70
自引率
5.80%
发文量
271
审稿时长
19 days
期刊介绍: The Journal of Hospital Infection is the editorially independent scientific publication of the Healthcare Infection Society. The aim of the Journal is to publish high quality research and information relating to infection prevention and control that is relevant to an international audience. The Journal welcomes submissions that relate to all aspects of infection prevention and control in healthcare settings. This includes submissions that: provide new insight into the epidemiology, surveillance, or prevention and control of healthcare-associated infections and antimicrobial resistance in healthcare settings; provide new insight into cleaning, disinfection and decontamination; provide new insight into the design of healthcare premises; describe novel aspects of outbreaks of infection; throw light on techniques for effective antimicrobial stewardship; describe novel techniques (laboratory-based or point of care) for the detection of infection or antimicrobial resistance in the healthcare setting, particularly if these can be used to facilitate infection prevention and control; improve understanding of the motivations of safe healthcare behaviour, or describe techniques for achieving behavioural and cultural change; improve understanding of the use of IT systems in infection surveillance and prevention and control.
期刊最新文献
Drain decontamination using in-situ generated ozone. Factors associated with core competencies of infection prevention and control practitioners in 511 hospitals: A large cross-sectional survey in Guizhou in southwest China. Prognosis analysis and infection-related risk factors of multidrug-resistant bacteria isolated from a general hospital in China, 2019-2023. Survey of healthcare-associated sink infrastructure, and sink trap antibiotic residues and biochemistry, in 29 UK hospitals. Optimization and evaluation of new decontamination procedures inactivating human prions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1